Language:
English
繁體中文
Help
回圖書館首頁
手機版館藏查詢
Login
Back
Switch To:
Labeled
|
MARC Mode
|
ISBD
Regulation of autoreactive B cells d...
~
The University of North Carolina at Chapel Hill., Biology, Microbiology.
Linked to FindBook
Google Book
Amazon
博客來
Regulation of autoreactive B cells during innate immune responses.
Record Type:
Language materials, printed : Monograph/item
Title/Author:
Regulation of autoreactive B cells during innate immune responses./
Author:
Rutan, Jennifer Ann.
Description:
85 p.
Notes:
Source: Dissertation Abstracts International, Volume: 69-11, Section: B, page: 6558.
Contained By:
Dissertation Abstracts International69-11B.
Subject:
Biology, Microbiology. -
Online resource:
http://pqdd.sinica.edu.tw/twdaoeng/servlet/advanced?query=3335417
ISBN:
9780549900580
Regulation of autoreactive B cells during innate immune responses.
Rutan, Jennifer Ann.
Regulation of autoreactive B cells during innate immune responses.
- 85 p.
Source: Dissertation Abstracts International, Volume: 69-11, Section: B, page: 6558.
Thesis (Ph.D.)--The University of North Carolina at Chapel Hill, 2008.
A diverse repertoire of B cell specificities is critical to combat pathogenic threats, but this diversity is tinged with the threat of autoimmunity. Autoimmune diseases such as systemic lupus erythematosus (SLE) underscore the need for strict regulation of B cell activation during immune responses. Regulation of the adaptive immune response is dependent on B cell receptor (BCR) ligation, affinity of the BCR-antigen interaction, and the presence of costimulatory molecules. Mechanisms of central tolerance and peripheral tolerance eradicate B cells that inappropriately bind self-antigens. Autoreactive B cells that escape these mechanisms of tolerance and encounter antigen in the absence of costimulatory signals enter an unresponsive state known as anergy. Anergic B cells do not differentiate into plasma cells, activate transcription factors such as Blimp-1 and XBP-1, or secrete immunoglobulin (Ig). B cells can also be activated by toll-like receptor (TLR) ligands and contribute to the innate immune response, the first line of defense against pathogens. Bacterial and viral components are the archetypical TLR ligands, but endogenous DNA and RNA can also bind TLRs and activate the innate immune system. Therefore, it is critical to regulate the innate immune response to prevent autoimmunity, and this regulation requires unique mechanisms that are not necessarily dependent on BCR ligation. Ideally, these mechanisms would also discriminate between naive and chronically antigen-experienced B cells, allowing naive B cells to respond to threats while potentially autoreactive B cells remain quiescent. We have recently described a mechanism where antigen-experienced B cells are regulated by IL-6 and sCD40L released by dendritic cells (DCs) and macrophages (Mphis) during innate immune responses. Naive B cells are unaffected by these factors, permitting a robust immune response in the absence of autoimmunity. IL-6/sCD40L-mediated repression is dependent on ERK activation and "repressed" antigen-experienced cells exhibit a decrease in activated ERK in the nucleus. Identifying new targets for SLE therapies could enable specific regulation of antigen-experienced B cells instead of non-specific B cell depletion and immunosuppression.
ISBN: 9780549900580Subjects--Topical Terms:
1017734
Biology, Microbiology.
Regulation of autoreactive B cells during innate immune responses.
LDR
:03326nam 2200313 a 45
001
858254
005
20100712
008
100712s2008 ||||||||||||||||| ||eng d
020
$a
9780549900580
035
$a
(UMI)AAI3335417
035
$a
AAI3335417
040
$a
UMI
$c
UMI
100
1
$a
Rutan, Jennifer Ann.
$3
1025299
245
1 0
$a
Regulation of autoreactive B cells during innate immune responses.
300
$a
85 p.
500
$a
Source: Dissertation Abstracts International, Volume: 69-11, Section: B, page: 6558.
502
$a
Thesis (Ph.D.)--The University of North Carolina at Chapel Hill, 2008.
520
$a
A diverse repertoire of B cell specificities is critical to combat pathogenic threats, but this diversity is tinged with the threat of autoimmunity. Autoimmune diseases such as systemic lupus erythematosus (SLE) underscore the need for strict regulation of B cell activation during immune responses. Regulation of the adaptive immune response is dependent on B cell receptor (BCR) ligation, affinity of the BCR-antigen interaction, and the presence of costimulatory molecules. Mechanisms of central tolerance and peripheral tolerance eradicate B cells that inappropriately bind self-antigens. Autoreactive B cells that escape these mechanisms of tolerance and encounter antigen in the absence of costimulatory signals enter an unresponsive state known as anergy. Anergic B cells do not differentiate into plasma cells, activate transcription factors such as Blimp-1 and XBP-1, or secrete immunoglobulin (Ig). B cells can also be activated by toll-like receptor (TLR) ligands and contribute to the innate immune response, the first line of defense against pathogens. Bacterial and viral components are the archetypical TLR ligands, but endogenous DNA and RNA can also bind TLRs and activate the innate immune system. Therefore, it is critical to regulate the innate immune response to prevent autoimmunity, and this regulation requires unique mechanisms that are not necessarily dependent on BCR ligation. Ideally, these mechanisms would also discriminate between naive and chronically antigen-experienced B cells, allowing naive B cells to respond to threats while potentially autoreactive B cells remain quiescent. We have recently described a mechanism where antigen-experienced B cells are regulated by IL-6 and sCD40L released by dendritic cells (DCs) and macrophages (Mphis) during innate immune responses. Naive B cells are unaffected by these factors, permitting a robust immune response in the absence of autoimmunity. IL-6/sCD40L-mediated repression is dependent on ERK activation and "repressed" antigen-experienced cells exhibit a decrease in activated ERK in the nucleus. Identifying new targets for SLE therapies could enable specific regulation of antigen-experienced B cells instead of non-specific B cell depletion and immunosuppression.
590
$a
School code: 0153.
650
4
$a
Biology, Microbiology.
$3
1017734
650
4
$a
Health Sciences, Immunology.
$3
1017716
690
$a
0410
690
$a
0982
710
2
$a
The University of North Carolina at Chapel Hill.
$b
Biology, Microbiology.
$3
1025298
773
0
$t
Dissertation Abstracts International
$g
69-11B.
790
$a
0153
790
1 0
$a
Arnold, Larry W.
$e
committee member
790
1 0
$a
Clarke, Stephen H.
$e
committee member
790
1 0
$a
Frelinger, Jeffrey A.
$e
committee member
790
1 0
$a
Ting, Jenny P. Y.
$e
committee member
790
1 0
$a
Vilen, Barbara J.
$e
committee member
791
$a
Ph.D.
792
$a
2008
856
4 0
$u
http://pqdd.sinica.edu.tw/twdaoeng/servlet/advanced?query=3335417
based on 0 review(s)
Location:
ALL
電子資源
Year:
Volume Number:
Items
1 records • Pages 1 •
1
Inventory Number
Location Name
Item Class
Material type
Call number
Usage Class
Loan Status
No. of reservations
Opac note
Attachments
W9073128
電子資源
11.線上閱覽_V
電子書
EB W9073128
一般使用(Normal)
On shelf
0
1 records • Pages 1 •
1
Multimedia
Reviews
Add a review
and share your thoughts with other readers
Export
pickup library
Processing
...
Change password
Login